<?xml version="1.0" encoding="UTF-8"?>
<p id="p0105">To manage the COVID-19 antipyretics and analgesics are directed. Moreover, hydration is maintained and also the respiratory system is supported by mechanical ventilation or extracorporeal membrane oxygenation. In case of bacterial infection along with COVID-19 antibiotics are found beneficial. We may use chloroquine and hydroxychloroquine having synergistic effects, but further studies needed (
 <xref rid="bb0075" ref-type="bibr">De Wit et al., 2020</xref>; 
 <xref rid="bb0180" ref-type="bibr">Ozaslan et al., 2020</xref>). Also, we have the option of Favipiravir and Remdesivir which were trialed by China and Japan but further studies are required (
 <xref rid="bb0090" ref-type="bibr">Fu et al., 2020</xref>; 
 <xref rid="bb0130" ref-type="bibr">Hui et al., 2020</xref>).
</p>
